The global cell culture media market size was valued at USD 4.8 Billion in 2021 and is expected to surpass USD 10.9 Billion by 2030, expanding at a CAGR of 7.2% during the forecast period, 2022–2030. The growth of the market is attributed to the rising demand for advanced cell development facilities and massive R&D programs for new stem cell media development by key players.
Cell culture media refers to the process of using nutrients and other components that help in the proper development of stem cell culture. Cell culture is a part of cell biology and biochemistry study that examines the relationships and interactions between cell and disease-causing agents such as viruses and bacteria.
The cell culture medium represents a vital aspect of the cultural environment that regulates the cell development cycle by providing essential nutrients such as serum, amino acids, glucose, inorganic salts, and vitamins. It also provides other several growth factors and hormones for cell growth by regulating the osmotic pressure and the pH of the culture.
The traditional cell culture experiments totally depend upon the use of natural media, which are primarily extracted from body tissues and fluids. However, with the advancements in technologies, the experiments now adopt artificial media such as basal media and balanced salt solutions to enhance the result of stem cell development. Using these cell culture, biotech organizations can identify the root cause of disease and examine the effects of the drugs available or helps in the development of new drugs for the disease treatment.
The COVID-19 pandemic had a positive impact on the market as several pharmaceutical and biotechnology firms geared up in the quest for a cure for the virus. Many research centers and academic research institutes entered into several collaborations with pharma and biotech companies to develop vaccines or antiviral drugs to fight the virus spread. Since cell culture represents a key component of drug development, the demand for cell culture media increased significantly during the pandemic.
Market Trends, Drivers, Restraints, and Opportunities
- Rising geriatric population with chronic illness and wide prevalence of several life-threatening diseases are key factors driving the market.
- Advancements in cell culture technologies and rising popularity of cell-based vaccines are likely to boost the market during the forecast period.
- Rapid expansion of the pharmaceutical industry and extensive programs of microbiology research with heavy funding from key players present other key drivers of the market.
- High cost of stem cell-development research and ethical concerns related to cell biology research are the main challenges to the market expansion.
- Innovation in cell culture media and increasing demand for personalized medicine for disease treatment are offering wide growth opportunities for the market.
Cell Culture Media Market Scoope
The report on the global cell culture media market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
Cell Culture Media Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2021
|
Historic Data
|
2019–2020
|
Forecast Period
|
2022–2030
|
Segmentation
|
Types (Stem Cell, Classical & Salts, Chemically Defined, Specialty, and Serum-free [CHO, BHK, and Vero Cell]), Applications (Diagnostics, Gene Therapy, Tissue Culture & Engineering, and Biopharmaceutical Manufacturing [mAbs and Vaccine]), and End-users (Biotechnology and Pharmaceutical)
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Danaher Corporation; Merck KGaA; CSL Limited; Lonza Group AG; Thermo Fisher Scientific, Inc.; and Sartorius AG
|
Cell Culture Media Market Segment Insights
Serum-free segment to expand at a rapid pace
Based on types, the global cell culture media market is divided into stem cell, classical & salts, chemically defined, specialty, and serum-free. The serum-free segment is further classified as CHO, BHK, and vero cell. The serum-free segment accounted for a dominant share of the market in 2021 and is expected to expand at a rapid pace during the forecast period due to its rising popularity for several advantages over other media types. Serum-free media offer certain advantages such as reducing the risk of serum-borne contamination, enhancing growth and productivity, and consistent performance of cell culture.
Cell-based vaccine development drives the biopharmaceutical manufacturing segment
In terms of applications, the market is segmented into diagnostics, gene therapy, tissue culture & engineering, and biopharmaceutical manufacturing. The biopharmaceutical manufacturing segment is further bifurcated into mAbs and vaccines. The biopharmaceutical manufacturing segment held a major share of the market in 2021 and is projected to exhibit a robust growth rate during the forecast period due to massive investment in cell-based vaccine development by biopharmaceutical companies.
R&D programs for new cell development fuel the pharmaceutical segment
On the basis of end-users, the global cell culture media market is bifurcated into biotechnology and pharmaceutical. The pharmaceutical segment is projected to register a considerable CAGR during the forecast period owing to wide R&D programs for the development of new cell culture media technology and the manufacturing of personalized medicines for patients. On the other hand, the biotechnology segment is anticipated to account for a major market share during the forecast period owing to increasing spending on biotech research by academic institutions and biotechnology organizations.
North America holds a dominant market share
In terms of regions, the global cell culture media market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America accounted for a large market share in 2021 and is expected to constitute a key share of the market during the projected owing to the well-establishment of biotechnology & pharmaceutical industries and favorable government initiatives in the development of new biotech and pharma research centers. Moreover, high investment in stem-cell research by key regional market players presents another key driver of the market in the region.
Segments
The global cell culture media market has been segmented on the basis of
Types
- Stem Cell
- Classical & Salts
- Chemically Defined
- Specialty
- Serum-free
Applications
- Diagnostics
- Gene Therapy
- Tissue Culture & Engineering
- Biopharmaceutical Manufacturing
End-users
- Biotechnology
- Pharmaceutical
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
Competitive Landscape
Key players competing in the global cell culture media market are Danaher Corporation; Merck KGaA; CSL Limited; Lonza Group AG; Thermo Fisher Scientific, Inc.; and Sartorius AG. Some of these players have adopted a series of business development strategies including merger and acquisition, entering into partnerships and collaboration, product launches, and production capacity expansion to expand their consumer base and enhance their market share.
For instance,
-
Seqirus UK Limited, a subsidiary of an Australia-based biotech company, CSL Limited received the approval of its latest monovalent vaccine, AUDENZ from the United States Food and Drug Administration in February 2020. AUDENZ is a cell-based Influenza A (H5N1) monovalent vaccine for the use of patients, who are six months old and above.